Canada markets closed
  • S&P/TSX

    18,480.98
    -521.70 (-2.75%)
     
  • S&P 500

    3,693.23
    -64.76 (-1.72%)
     
  • DOW

    29,590.41
    -486.27 (-1.62%)
     
  • CAD/USD

    0.7360
    -0.0055 (-0.74%)
     
  • CRUDE OIL

    79.43
    -4.06 (-4.86%)
     
  • BTC-CAD

    25,918.08
    -130.86 (-0.50%)
     
  • CMC Crypto 200

    434.61
    -9.92 (-2.23%)
     
  • GOLD FUTURES

    1,651.70
    -29.40 (-1.75%)
     
  • RUSSELL 2000

    1,679.59
    -42.72 (-2.48%)
     
  • 10-Yr Bond

    3.6970
    -0.0110 (-0.30%)
     
  • NASDAQ

    10,867.93
    -198.88 (-1.80%)
     
  • VOLATILITY

    29.92
    +2.57 (+9.40%)
     
  • FTSE

    7,018.60
    -140.92 (-1.97%)
     
  • NIKKEI 225

    27,153.83
    -159.30 (-0.58%)
     
  • CAD/EUR

    0.7588
    +0.0052 (+0.69%)
     

Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond

·6 min read
Got $20? These 3 Healthcare Stocks Could Be Bargain Buys for 2022 and Beyond

On top of those pluses, these three companies all have a history of offering above-average dividends, making them solid long-term value bargains. Takeda is a Japanese biopharmaceutical company that focuses on gastroenterology, oncology, neuroscience, and rare diseases. The company's stock is up more than 9% this year, currently trading at just shy of $15.